IRIS UniCatt

Iorio, Raffaele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.606
EU - Europa 3.846
AS - Asia 3.278
SA - Sud America 834
AF - Africa 102
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.687
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.451
DE - Germania 1.489
SG - Singapore 1.455
CN - Cina 981
BR - Brasile 674
SE - Svezia 591
IT - Italia 401
UA - Ucraina 284
FR - Francia 239
GB - Regno Unito 201
VN - Vietnam 191
IN - India 177
IE - Irlanda 162
FI - Finlandia 142
ID - Indonesia 112
RU - Federazione Russa 93
CA - Canada 78
PL - Polonia 55
AR - Argentina 54
TR - Turchia 54
MX - Messico 52
HK - Hong Kong 46
BD - Bangladesh 38
BE - Belgio 34
IQ - Iraq 34
JP - Giappone 31
KR - Corea 31
CI - Costa d'Avorio 30
AT - Austria 27
EC - Ecuador 27
ES - Italia 24
NL - Olanda 24
ZA - Sudafrica 23
CO - Colombia 20
SA - Arabia Saudita 19
PK - Pakistan 17
CH - Svizzera 16
VE - Venezuela 16
IR - Iran 14
PY - Paraguay 14
LT - Lituania 13
MA - Marocco 13
AU - Australia 12
CL - Cile 12
UZ - Uzbekistan 11
EG - Egitto 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
KE - Kenya 8
JO - Giordania 7
OM - Oman 7
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
BY - Bielorussia 5
DZ - Algeria 5
IL - Israele 5
KZ - Kazakistan 5
LV - Lettonia 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
MD - Moldavia 4
NP - Nepal 4
RO - Romania 4
BG - Bulgaria 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MM - Myanmar 3
PA - Panama 3
RS - Serbia 3
AL - Albania 2
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LY - Libia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BZ - Belize 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
Totale 12.672
Salva come PNG Salva come JPEG
Città #
Chandler 684
Singapore 660
Ashburn 562
Beijing 205
Jacksonville 205
New York 199
Ann Arbor 180
Dublin 154
San Mateo 131
Hefei 130
Los Angeles 129
Nanjing 105
Nürnberg 100
Jakarta 96
Woodbridge 86
Chicago 85
Dearborn 85
Houston 76
Munich 75
Rome 69
Wilmington 68
Ho Chi Minh City 67
São Paulo 62
Frankfurt am Main 59
Boston 58
Milan 57
Dallas 55
Marseille 50
Bremen 49
Buffalo 48
Cattolica 48
Hanoi 48
Moscow 47
Hong Kong 44
North Bergen 43
Helsinki 40
Lawrence 39
Princeton 39
Redmond 38
Redwood City 36
Kent 35
Nanchang 35
Seattle 35
Brussels 34
Warsaw 34
Izmir 32
Turku 32
Seoul 31
Abidjan 30
Düsseldorf 30
Norwalk 30
Santa Clara 28
London 27
Hangzhou 26
Nuremberg 26
Montreal 24
Atlanta 23
Boardman 20
Detroit 20
Mountain View 20
Pune 20
Shanghai 20
Shenyang 20
Denver 19
Ottawa 19
Brooklyn 18
Mexico City 18
Orem 18
Phoenix 18
Rio de Janeiro 18
Stockholm 18
Tianjin 18
Tokyo 18
Belo Horizonte 17
University Park 17
Chennai 16
Johannesburg 16
Trieste 16
Fairfield 15
Monza 15
Poplar 15
Amsterdam 14
Changsha 14
Leawood 14
San Francisco 14
Salvador 13
Hebei 12
Manchester 12
Roubaix 12
Wroclaw 12
Baghdad 11
Lappeenranta 11
Porto Alegre 11
Washington 11
Bexley 10
Brasília 10
Campinas 10
Dhaka 10
Falkenstein 10
Paris 10
Totale 6.173
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 248
pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. 226
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 207
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 206
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 196
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 185
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 178
Multiple Sclerosis attacks triggered by hyperprolactinemia 178
Acute necrotizing Encephalopathy during novel influenza A (H1N!) virus infection 178
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 174
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 171
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 169
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 168
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 165
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 163
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 162
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 161
A Case of Hemiabdominal Myoclonus 157
Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. 154
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 153
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 152
Circulating CD8+CD56-Perforin+ T cells are increased in Multiple Sclerosis patients 150
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 150
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis 150
3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies 149
Replay to Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E. 145
Copper deficiency myelopathy: A report of two cases 145
A b3 type-thymoma in a 7-year-old child with myasthenia gravis 142
CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment 140
Myasthenia gravis with antibodies to MuSK: an update 138
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 137
Type 1 immune response in progressive Multiple Sclerosis 135
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer. 134
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 133
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 133
Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic etiology 129
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 128
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 127
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 126
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 125
Efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders: A systematic review and meta-analysis 122
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 122
Breastfeeding and multiple sclerosis 121
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 121
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review 120
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients 118
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy 118
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 118
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 117
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 116
A Case of Hemiabdominal Myoclonus 115
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 115
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 115
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 110
Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report 109
SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) 108
gc) Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. 108
Multiple sclerosis attacks triggered by hyperprolactinemia 107
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 106
Imaging Features of Varicella Zoster Virus Cranial Multiple Mononeuropathies 105
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 104
Focal hyperhidrosis in tumefactive Multiple Sclerosis 103
Glioblastoma in multiple sclerosis: a case report 103
gc) T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. 99
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 99
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 98
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies 95
A score that predicts aquaporin-4 IgG positivity in patients with longitudinally extensive transverse myelitis 92
Nine syndrome 91
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 90
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor 88
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 86
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 83
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4 83
Movement disorders phenomenology in focal motor seizures 83
Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations 82
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 81
Cancer Frequency in MuSK Myasthenia Gravis and Histological Evidence of Paraneoplastic Etiology 80
Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility 79
Controversies in Ocular Myasthenia Gravis 79
Isolated Memory Loss in Anti-NMDAR Encephalitis 77
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 77
Complement inhibitor therapy as a steroid-sparing strategy in generalized myasthenia gravis 75
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience 73
The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy 73
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study 67
Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes 65
Concordance between radioimmunoassay and fixed cell-based assay in subjects without myasthenia gravis: optimizing the diagnostic approach 65
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience 64
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 64
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 63
Teaching Video NeuroImage: Bilateral Eyelid Opening Apraxia in a Patient With Top of the Basilar Syndrome 62
Paraneoplastic neurological syndromes 62
Grading the severity of autoimmune encephalitis: Advances and pitfalls 60
Diagnostics of paraneoplastic neurological syndromes 60
Immunotherapy improves sleep and cognitive impairment in anti-IgLON5 encephalopathy 58
Epilepsia Partialis Continua as a manifestation of aquaporin-4 autoimmunity 57
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II) 54
Totale 12.003
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021406 0 0 0 0 0 35 83 23 70 42 138 15
2021/2022802 75 48 24 74 41 18 22 101 36 62 123 178
2022/20231.856 200 248 148 307 98 225 98 159 241 52 52 28
2023/20241.034 36 247 36 113 26 188 69 44 18 29 112 116
2024/20252.184 36 81 146 80 115 58 96 98 347 200 461 466
2025/20263.577 939 179 368 862 1.050 179 0 0 0 0 0 0
Totale 12.855